Adalimumab-adbm injection is a citrate-free formulation and is supplied as 40mg/0.8mL, 20mg/0.4mL and 10mg/0.2mL prefilled syringes and as a 40mg/0.8mL prefilled autoinjector.

As Medicare Advantage, or Medicare Part C, plans must include Part B, they may also cover Humira injections on an outpatient basis. Many Advantage plans also include Part D prescription drug coverage.